Related Experiment Videos
Interaction of chemopreventive agents with hormone receptors
1Department of Nutrition and Dietetics, King's College London, Kensington, UK.
Abstract:
Our understanding of the mechanisms by which chemopreventive agents interact with hormone receptors is clearly important both to current strategies for the treatment and prevention of cancer and to future endeavours of rational drug design, perhaps aided by computer-based molecular modelling. This chapter focuses on the importance of the interaction of the nonsteroidal antiestrogen drug tamoxifen (widely used in the treatment of breast cancer and currently being proposed for the prevention of breast cancer) with the estrogen receptor to its mode of action. The improved efficacy of new tamoxifen derivatives and of the steroidal pure estrogen antagonists is also considered, and the importance of hormone-receptor mutations in the development of drug resistance in cancer cells is discussed.
Insights
Tamoxifen
Area of Science:
- Oncology
- Endocrinology
- Pharmacology
Background:
- Hormone receptors play a crucial role in cancer development and treatment.
- Tamoxifen is a key nonsteroidal antiestrogen drug used in breast cancer treatment and prevention.
- Understanding drug-receptor interactions is vital for cancer therapy and drug design.
Purpose of the Study:
- To explore the interaction between tamoxifen and the estrogen receptor.
- To discuss the efficacy of novel tamoxifen derivatives and steroidal estrogen antagonists.
- To examine the role of hormone-receptor mutations in cancer drug resistance.
Main Methods:
- Literature review focusing on tamoxifen's mechanism of action.
- Analysis of studies on new antiestrogen derivatives and antagonists.
- Discussion of research on hormone-receptor mutations and drug resistance.
Main Results:
- Tamoxifen's interaction with the estrogen receptor is central to its therapeutic effects.
- Newer tamoxifen derivatives and steroidal antagonists show promising efficacy.
- Hormone-receptor mutations can lead to acquired resistance to cancer therapies.
Conclusions:
- Elucidating tamoxifen-estrogen receptor interactions is critical for cancer treatment and prevention.
- Further research into novel antiestrogens and resistance mechanisms is warranted.
- Computer-aided drug design can benefit from understanding these molecular interactions.